bpc-157 regulatory status fda not approved for human use Targets GLP-1 and Peptide Compounding, Advertising and 'Research Only' Labeling BPC-157: What you need to
Description
Thymosin Beta-4 / TB-500 literature is similarly available
Sikiric P, Mikus D, Seiwerth S, et al

[DOI] [PubMed] [Google Scholar] 88.Barisic I., Balenovic D., Klicek R., Radic B., Nikitovic B., Drmic D., Udovicic M., Strinic D., Bardak D., Berkopic L., et al

In plain terms, it triggers the formation of new blood vessels where tissue is damaged

First, there is regional enrichment of various genes in identified subsets of neurons along the length of the gut, likely reflective of differences in the specific functional circuits (193)
The SURMOUNT-1 data showed 75% fat loss and 25% lean mass loss with tirzepatide alone